Similar articles

• Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.

  Hermel DJ, McKinnon WC, Wood ME, Greenblatt MS. Hermel DJ, et al. Fam Cancer. 2017 Jan;16(1):159-166. doi: 10.1007/s10689-016-9913-5. Fam Cancer. 2017. PMID: 27401692
• Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.

  Crawford B, Adams SB, Sittler T, van den Akker J, Chan S, Leitner O, Ryan L, Gil E, van 't Veer L. Crawford B, et al. Breast Cancer Res Treat. 2017 Jun;163(2):383-390. doi: 10.1007/s10549-017-4181-0. Epub 2017 Mar 9. Breast Cancer Res Treat. 2017. PMID: 28281021 Free PMC article.
• Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.

  Frey MK, Kim SH, Bassett RY, Martineau J, Dalton E, Chern JY, Blank SV. Frey MK, et al. Gynecol Oncol. 2015 Nov;139(2):211-5. doi: 10.1016/j.ygyno.2015.08.006. Epub 2015 Aug 18. Gynecol Oncol. 2015. PMID: 26296696
• Multi-gene Panel Testing in Breast Cancer Management.

  Fountzilas C, Kaklamani VG. Fountzilas C, et al. Cancer Treat Res. 2018;173:121-140. doi: 10.1007/978-3-319-70197-4_8. Cancer Treat Res. 2018. PMID: 29349761 Review.
• Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.

  Lerner-Ellis J, Khalouei S, Sopik V, Narod SA. Lerner-Ellis J, et al. Expert Rev Anticancer Ther. 2015;15(11):1315-26. doi: 10.1586/14737140.2015.1090879. Epub 2015 Nov 2. Expert Rev Anticancer Ther. 2015. PMID: 26523341 Review.